Adiposity Is a Key Correlate of Circulating Fibroblast Growth Factor-21 Levels in African Males with or without Type 2 Diabetes Mellitus

J Obes. 2018 Sep 12:2018:7461903. doi: 10.1155/2018/7461903. eCollection 2018.

Abstract

Background: Fibroblast growth factor-21 is an endocrine regulator with therapeutic and diagnostic potential. The levels and pattern of circulating FGF-21 have been described mainly in European and Asian populations. Given its strong association with adiposity, and the reported ethnic variabilities in body composition, examining FGF-21 in an African population is crucial.

Methods: We measured levels of circulating FGF-21 in 207 overweight and obese Tanzanian males with or without type 2 diabetes mellitus (T2DM), and using statistical approaches, we explored their relationship with anthropometric and biochemical parameters.

Results: Consistent with previous reports from European and Asian populations, we found higher levels of FGF-21 in people with T2DM compared to those without the disease. Based on statistical models, measures of adiposity explained up to 59% of the variability in FGF-21 levels in the circulation.

Conclusion: Levels of circulating FGF-21 in overweight and obese African males are higher in T2DM and strongly correlate with measures of adiposity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity*
  • Black People
  • Diabetes Mellitus, Type 2 / blood*
  • Fibroblast Growth Factors / blood*
  • Humans
  • Male
  • Middle Aged
  • Obesity / blood
  • Overweight / blood
  • Tanzania

Substances

  • fibroblast growth factor 21
  • Fibroblast Growth Factors